Device Trial Radar · NCT05742711
Efficacy of PENS of the Auricle as an Opioid Sparing Postoperative Analgesic Technique in Cancer Endometrium and Cancer Cervix Patients
Last checked: Nov 20, 2026Latest source record: Sep 5, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
48
Actual
Start
May 16, 2023
Primary completion
Jan 13, 2025
Study completion Jan 13, 2025
Sponsor
- Lead sponsor
- DyAnsys, Inc.Not on our public-company list
- Sponsor type
- Industry
- First posted
- Feb 24, 2023
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated device
- No
- Who can join
- Female only, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Pain relief following laparotomy surgery requires a variety of techniques including invasive ones like epidural or nerve blocks along with different classes of drugs, out of which opioids are most predominant. Each of these drugs have with their own set of advantages and also side effects. An ideal common system of analgesia is not possible due to patient variability. And no drug is devoid of side effects. Hence the aim is to ensure effective analgesia using drugs or techniques which are minimally invasive with negligible side effects.
Conditions
- Cancer of Endometrium
- Cancer of Cervix
Interventions
Primary ReliefDevice
Continuous neurostimulation with a set of pre-assigned stimulation parameters.
Primary Relief - Sham DeviceDevice
Standard treatment with the application of sham device shall be followed with additional analgesics available if necessary.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Numeric Rating Scale (NRS)Time frame: 0 - 4 days; 0 hours, 2 hours, 4 hours, 8 hours, 12 hours, 18 hours, 24 hours, 36 hours, 48 hours, 72 hours, 96 hours. Outcomes will be reported as an average over each individual postoperative day and as an average over 5 days independently for rest.
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Cancer Institute,(Wia)
Chennai, Tamil Nadu, India
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.